Relapsed or Refractory Haematological Malignancies Including
1 clinical trials · Condition
◉ Watch Relapsed or Refractory Haematological Malignancies Including
| Record | Firm | Date |
|---|---|---|
| Study to Assess Safety, Tolerability, Pharmacokinetics and Antitumor Activity of AZD4573 in Relapsed/Refractory Haematological Malignancies (NCT03263637) | AstraZeneca | 2017-10-24 |
Track Relapsed or Refractory Haematological Malignancies Including automatically
Every clearance here is in the API, with alerts when new ones post.